QuantiFERON

Jul 23, 2019

Global Latent Tuberculosis Infection Testing Market 2019-2023: Rising Prevalence of HIV and Increasing Government Initiatives to Drive Market Growth

Sep 25, 2018

Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec

Feb 19, 2018

Aeras Highlights Commitment to Eradicating the World's Leading Infectious Disease Killer at the 5th Global Forum on Tuberculosis

Feb 19, 2018

Results from Innovative Phase 2 Tuberculosis Vaccine Trial Offer Potential for New BCG Revaccination Strategies, Hope For Subunit Vaccines

Jan 08, 2018

QIAGEN and DiaSorin Partner to Offer Fully Automated Tuberculosis Detection With QuantiFERON-TB Gold Plus Available on LIAISON Analyzer Systems

Dec 15, 2017

QIAGEN and Oxford Immunotec Settle Patent Infringement Lawsuit

Oct 05, 2017

QIAGEN Launches Fourth-generation QuantiFERON®-TB Gold Plus in the U.S.

Jul 27, 2017

QIAGEN Reports Results for Second Quarter and First Half of 2017

Jul 26, 2017

Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections

Jun 22, 2017

French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test

Jun 08, 2017

QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval